Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Efficacy of Lumbar Plexus Bloc After Hip Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00150865
Recruitment Status : Completed
First Posted : September 8, 2005
Last Update Posted : November 1, 2017
Sponsor:
Information provided by:
University Hospital, Angers

Brief Summary:

Compare lumbar plexus block with ropivacaine 0.475%, 0.4 ml/kg to saline. Each group randomized, includes 30 patients. block performed preoperatively Surgery under general anesthesia. Postoperative evaluation of pain (VAS) as first endpoint, and also morphine consumption via PCA device. Follow-up : 24h.

Expectation : sizeable reduction of pain with block, of duration.


Condition or disease Intervention/treatment Phase
Pain Postoperative Drug: ropivacaine Not Applicable

Detailed Description:

Compare lumbar plexus block (randomized)

  • ropivacaine 0.475%, 0.4 ml/kg
  • saline 0.4 ml/kg . Each group includes 30 patients.

Block performed preoperatively.

Surgery under general anesthesia (sufentanil, propofol, atracurium ; maintenance : sevoflurane and nitrous oxide in O2. Sufentanil added peroperatively as clinically needed.

Postoperative evaluation of pain (VAS, by an independant blind observer) as first endpoint, and also morphine consumption via PCA device.

Adverse effects (nausea, vomiting, etc) recorded

Follow-up : 24h. Expectation : sizeable reduction of pain with block, of duration.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Study of Posterior Lumbar Plexus Block for Pain Relief After Hip Surgery
Study Start Date : September 2001
Study Completion Date : March 2002

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. decrease of postoperative pain

Secondary Outcome Measures :
  1. decrease in morphine consumption
  2. duraration of analgesic effect


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • adults
  • ASA 1-3

Exclusion Criteria:

  • cognitive impairement
  • ASA IV

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00150865


Sponsors and Collaborators
University Hospital, Angers
Investigators
Layout table for investigator information
Study Director: laurent beydon, MD University Hospital, Angers
Principal Investigator: ibrahim okais, MD Clinique St Leonard
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00150865    
Other Study ID Numbers: CP 02-01
First Posted: September 8, 2005    Key Record Dates
Last Update Posted: November 1, 2017
Last Verified: September 2005
Keywords provided by University Hospital, Angers:
ropivacaine
posterior lumbar plexus block
hip arthroplasy
analgesia
postoperative
Additional relevant MeSH terms:
Layout table for MeSH terms
Ropivacaine
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents